Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Preliminary data reported for clinical study of UX-003 in mucopolysaccharidosis type VII

April 14, 2014

Adocia reports results from phase IIa study of ultra-fast-acting BioChaperone lispro

April 14, 2014

New clinical data on alirocumab for hypercholesterolemia presented

April 14, 2014

Aegerion Pharmaceuticals begins phase III trial of lomitapide in Japan

April 10, 2014

Bristol-Myers Squibb patents new endothelial lipase inhibitors

April 10, 2014

Phase IIb results presented for bococizumab for the treatment of hypercholesterolemia

April 10, 2014

Phase II interim results show improvements in infantile hypophosphatasia with asfotase alfa

April 10, 2014

AEM-28 enters phase I/II trial in refractory hypercholesterolemia

April 9, 2014

Novel anti-IAPP MAbs divulged by Neurimmune Holding

April 9, 2014

FDA extends PDUFA date for Afrezza review

April 7, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...